Dr. P.R. Raghavan (CEO, Founder of Nanorx Inc.) brings over four decades in the field of biochemistry and is the scientist behind Metadichol®, the patented formula in Nano-Ojas® products. The following papers and studies show the latitude of nano policosanol.

Bias Mitigation: Nanorx Inc. minimizes bias in Metadichol® research by outsourcing all experimental work to independent third-party laboratories across multiple countries on a fee-for-service basis. These labs conduct all assays, including assays and qRT-PCR, Western blotting RNA, and Micro array and sequencing methods etc., without involvement from Nanorx employees, reducing procedural and observer bias compared to typical industry-sponsored research. The company transparently discloses the author’s financial interest in Nanorx Inc. and provides detailed experimental methodologies, enhancing credibility. This approach strengthens objectivity and independent validation.

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Information is for educational purposes. If you have a medical condition or health concern, see your healthcare provider.